Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Adverse Events

Patients on treatment for latent TB infection (LTBI) or TB disease should report any signs and symptoms of adverse drug reactions to their health care provider, including

  • Unexplained anorexia, nausea or vomiting, dark urine*, or icterus (yellowing of skin or eyes)
  • Persistent paresthesia (tingling, numbness, or burning) of hands or feet
  • Persistent weakness, fatigue, fever, or abdominal tenderness
  • Easy bruising or bleeding
  • Blurred vision or changed vision

*Patients taking rifampin (RIF) or rifapentine (RPT) should be informed that they will notice a normal orange discoloration of body fluids, including urine and tears. Contact lenses may be permanently stained.

Patients should provide a list of current medications to avoid drug interactions. Some interactions to note:

  • Isoniazid (INH) increases blood levels of phenytoin (Dilantin) and disulfiram (Antabuse)
  • RIF and RPT decrease blood levels of many drugs including oral contraceptives, warfarin, sulfonureas, and methadone
  • RIF and RPT are contraindicated in HIV-infected individuals being treated with protease inhibitors (PIs) and most nonnucleoside reverse transcriptase inhibitors (NNRTIs)